Abstract
The discovery of new secondary metabolites is a challenge for biotechnologists due to the emergence of superbugs and drug resistance. Therefore, Streptomyces sp. have been widely studied by the pharmaceutical industry in the development of compounds with biological activity, such as antibiotics, antitumor and antiviral drugs. Among the metabolites biosynthesized by Streptomyces sp., there…